Inventor · disambiguated record
Jasbir Seehra
Also filed as: SEEHRA JASBIR · SEEHRA JASBIR S
110 granted patents·76 pending applications·2,884 citations·filing 1985–2025
99Inventor score
Files withACCELERON PHARMA INC109KEROS THERAPEUTICS INC28KNOPF JOHN14SEEHRA JASBIR14INST GENETICS LLC7
Top patents by PatentIndex Score
186 records- 0199US8703694B2Methods for increasing thermogenic adipocytesKNOPF JOHN·Filed 2012·Granted Apr 22, 2014·43 cites·42 claims
- 0299US8703927B2Isolated nucleotide sequences encoding GDF trapsSEEHRA JASBIR·Filed 2012·Granted Apr 22, 2014·57 cites·9 claims
- 0399US8343933B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2010·Granted Jan 1, 2013·91 cites·25 claims
- 0499US8252900B2Actriib-Fc polynucleotides, polypeptides, and compositionsKNOPF JOHN·Filed 2010·Granted Aug 28, 2012·92 cites·5 claims
- 0599US8216997B2Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activatorsSEEHRA JASBIR·Filed 2010·Granted Jul 10, 2012·100 cites·20 claims
- 0699US8178488B2Methods for increasing thermogenic adipocytesKNOPF JOHN·Filed 2010·Granted May 15, 2012·92 cites·18 claims
- 0799US8058229B2Method of increasing red blood cell levels or treating anemia in a patientSEEHRA JASBIR·Filed 2009·Granted Nov 15, 2011·97 cites·28 claims
- 0899US7842663B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2008·Granted Nov 30, 2010·135 cites·15 claims
- 0999US7709605B2ActRII receptor polypeptides, methods and compositionsACCELERON PHARMA INC·Filed 2005·Granted May 4, 2010·145 cites·29 claims
- 1099US7612041B2Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growthACCELERON PHARMA INC·Filed 2006·Granted Nov 3, 2009·132 cites·30 claims
- 1198US10889626B2Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levelsACCELERON PHARMA INC·Filed 2020·Granted Jan 12, 2021·4 cites·25 claims
- 1298US10829532B2Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levelsACCELERON PHARMA INC·Filed 2020·Granted Nov 10, 2020·4 cites·24 claims
- 1398US8629109B2Method for promoting bone growth using activin-actriia antagonistsKNOPF JOHN·Filed 2011·Granted Jan 14, 2014·57 cites·129 claims
- 1498US8361957B2Isolated GDF trap polypeptideACCELERON PHARMA INC·Filed 2011·Granted Jan 29, 2013·42 cites·14 claims
- 1598US8293881B2Isolated nucleic acid encoding a truncated ActRIIB fusion proteinSEEHRA JASBIR·Filed 2010·Granted Oct 23, 2012·73 cites·9 claims
- 1698US8128933B2Method of promoting bone growth by an anti-activin B antibodyKNOPF JOHN·Filed 2009·Granted Mar 6, 2012·49 cites·18 claims
- 1798US8067360B2Method for promoting bone growth using activin-ActRIIa antagonistsKNOPF JOHN·Filed 2008·Granted Nov 29, 2011·59 cites·26 claims
- 1898US7951771B2Activin-ActRIIa antagonists and uses for promoting bone growthACCELERON PHARMA INC·Filed 2008·Granted May 31, 2011·56 cites·17 claims
- 1997US10377996B2Methods of identifying ActRIIB variantsACCELERON PHARMA INC·Filed 2016·Granted Aug 13, 2019·24 cites·11 claims
- 2097US10259861B2Variants derived from ActRIIB and uses thereforACCELERON PHARMA INC·Filed 2016·Granted Apr 16, 2019·22 cites·11 claims
- 2197US10131700B2Methods for treating refractory anemia with ringed sideroblastsACCELERON PHARMA INC·Filed 2017·Granted Nov 20, 2018·20 cites·25 claims
- 2297US9932379B2Isolated nucleotide sequences encoding GDF trapsACCELERON PHARMA INC·Filed 2016·Granted Apr 3, 2018·19 cites·12 claims
- 2397US9745559B2Method for decreasing the body fat content in a subject by administering an ActRIIB proteinACCELERON PHARMA INC·Filed 2015·Granted Aug 29, 2017·22 cites·20 claims
- 2497US9353356B2Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumorACCELERON PHARMA INC·Filed 2013·Granted May 31, 2016·36 cites·45 claims
- 2597US8367611B2Activin-actriia antagonists for inhibiting germ cell maturationACCELERON PHARMA INC·Filed 2011·Granted Feb 5, 2013·35 cites·19 claims
- 2697US8173601B2Activin-ActRIIa antagonists and uses for treating multiple myelomaKNOPF JOHN·Filed 2008·Granted May 8, 2012·42 cites·21 claims
- 2797US7960343B2Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretionACCELERON PHARMA INC·Filed 2008·Granted Jun 14, 2011·48 cites·40 claims
- 2897US6828344B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 7, 2004·109 cites·16 claims
- 2997US6630496B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Oct 7, 2003·145 cites·18 claims
- 3097US6500853B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 31, 2002·104 cites·19 claims
- 3196US11717558B2Nucleic acid molecules encoding activin receptor type IIA variantsKEROS THERAPEUTICS INC·Filed 2021·Granted Aug 8, 2023·6 cites·12 claims
- 3296US10689427B2Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levelsACCELERON PHARMA INC·Filed 2018·Granted Jun 23, 2020·7 cites·17 claims
- 3396US10358633B2Method for producing an ActRIIB-Fc fusion polypeptideACCELERON PHARMA INC·Filed 2017·Granted Jul 23, 2019·15 cites·7 claims
- 3496US9617319B2ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapyACCELERON PHARMA INC·Filed 2014·Granted Apr 11, 2017·21 cites·24 claims
- 3596US9526759B2Activin-actriia antagonists and uses for treating or preventing breast cancerKNOPF JOHN·Filed 2008·Granted Dec 27, 2016·38 cites·34 claims
- 3696US9505813B2Use of GDF traps to treat anemiaACCELERON PHARMA INC·Filed 2013·Granted Nov 29, 2016·20 cites·63 claims
- 3796US9439945B2Isolated nucleotide sequences encoding GDF trapsACCELERON PHARMA INC·Filed 2014·Granted Sep 13, 2016·18 cites·15 claims
- 3896US9399669B2Variants derived from ActRIIBACCELERON PHARMA INC·Filed 2012·Granted Jul 26, 2016·27 cites·29 claims
- 3996US9181533B2Truncated ACTRIIB-FC fusion proteinACCELERON PHARMA INC·Filed 2012·Granted Nov 10, 2015·26 cites·19 claims
- 4096US9163075B2Isolated polynucleotide that encodes an ActRIIa-Fc fusion polypeptideACCELERON PHARMA INC·Filed 2013·Granted Oct 20, 2015·20 cites·33 claims
- 4196US9138459B2ACTRIIB-FC polynucleotides, polypeptides, and compositionsKNOPF JOHN·Filed 2012·Granted Sep 22, 2015·26 cites·14 claims
- 4296US8710016B2ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapySEEHRA JASBIR·Filed 2010·Granted Apr 29, 2014·29 cites·30 claims
- 4396US8138142B2Methods for increasing adiponectin in a patient in need thereofSEEHRA JASBIR·Filed 2010·Granted Mar 20, 2012·82 cites·17 claims
- 4495US12350313B2Activin receptor type IIa variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·3 cites·20 claims
- 4595US11884715B2Activin receptor type IIB variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2020·Granted Jan 30, 2024·6 cites·14 claims
- 4695US11090361B2Activin receptor type IIa variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2017·Granted Aug 17, 2021·11 cites·10 claims
- 4795US11013785B2Activin receptor type IIA variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2017·Granted May 25, 2021·12 cites·20 claims
- 4895US8765663B2Methods for increasing adiponectinSEEHRA JASBIR·Filed 2012·Granted Jul 1, 2014·38 cites·12 claims
- 4995US8338377B2BMP-ALK3 antagonists and uses for promoting bone growthSEEHRA JASBIR·Filed 2010·Granted Dec 25, 2012·20 cites·21 claims
- 5094US12269858B2Activin receptor type IIB variants and methods of use thereofKEROS THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·2 cites·13 claims
Showing the top 50 of 186 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →